MedPath
NMPA Approval

Levodopa and Benserazide Hydrochloride Tablets

国药准字H20254379

May 27, 2025

Drug Information

多巴丝肼片

片剂

左旋多巴0.1g与苄丝肼25mg(相当于盐酸苄丝肼28.5mg)

化学药品

May 27, 2025

Company Information

Applicant Company

湖北省武汉东湖新技术开发区生物园路8号

Manufacturing Company

湖北省远安县鸣凤大道99号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

多巴丝肼片 - NMPA 批准文号 | MedPath